GlassScriptPhysician profile
Angela K Cronin
NPI 1639347685
$1,150.21
in general payments reported to CMS, 2019-2025
15 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $258 · 2023: $312 · 2024: $208 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.93 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $580.08 | 2021-2025 | |
| Abbvie INC. | $177.25 | 2021-2023 | |
| Leo Pharma INC. | $58.70 | 2024-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $49.15 | 2024-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $49.05 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $36.80 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $32.99 | 2024 | |
| Janssen Biotech, INC. | $32.33 | 2022-2023 | Simponi, Simponi Aria, Remicade |
| Genentech USA, INC. | $30.11 | 2022-2024 | Erivedge |
| Amgen INC. | $22.67 | 2022 | |
| Ucb, INC. | $20.28 | 2025 | Bimzelx |
| Genzyme Corporation | $16.59 | 2021 | |
| Lilly USA, LLC | $16.14 | 2021 | |
| Pfizer INC. | $15.27 | 2024 | |
| Incyte Corporation | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Cronin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.